PAA 10.2% 22.0¢ pharmaust limited

PeteeteepooCan not agree with your statement that mpl hasn't...

  1. 8,657 Posts.
    lightbulb Created with Sketch. 1670
    Peteeteepoo
    Can not agree with your statement that mpl hasn't missed a target, the main endpoint for the phase 2b canine trial was to reach 18 out of 46 dogs showing the required improvement, it failed to reach this.
    The second thing with the phase 2b canine trial was to recruit 10 dogs in the US as a means of gaining registration now at best only 3 dogs recruited, with very poor out come, maybe the failure to recruit sufficient dogs in the US not a failure of MPL but a failure still.
    Some on here have very short memory.
    Yes so far all data from MND trial coming up trumps but now cash needed as it has been stated the mnd phase 2/3 trial to commence by end of June, 2.5 months away.
    35 days since data was submitted to FDA for ODD application and over 100 days since first application submitted
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
-0.025(10.2%)
Mkt cap ! $86.90M
Open High Low Value Volume
24.5¢ 24.5¢ 22.0¢ $405.6K 1.791M

Buyers (Bids)

No. Vol. Price($)
3 32271 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 53448 2
View Market Depth
Last trade - 16.10pm 30/04/2024 (20 minute delay) ?
Last
22.5¢
  Change
-0.025 ( 8.16 %)
Open High Low Volume
24.0¢ 24.0¢ 22.0¢ 900359
Last updated 15.56pm 30/04/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.